TO THE 110-TH ANNIVERSARY OF RENIN FINDING. FIGHT OF TITANS: ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND SARTANS

TO THE 110-TH ANNIVERSARY OF RENIN FINDING. FIGHT OF TITANS: ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND SARTANS

Show other versions (1)

Angiotensin converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARB) slow down progression of cardiovascular diseases and reduce risk of mortality and life threatening complications. What it is better to prescribe for patient in a concrete clinical case – ACE inhibitors or ARB?...

Full description

Bibliographic Details
Main Authors: L. N. Malay, A. N. Miroshnichenko, B. V. Sharykin, V. V. Konurovsky
Format: Article
Language:English
Published: Stolichnaya Izdatelskaya Kompaniya 2016-01-01
Series:Racionalʹnaâ Farmakoterapiâ v Kardiologii
Subjects:
angiotensin converting enzyme inhibitors
angiotensin ii receptor blockers
cardiovascular diseases
Online Access:https://www.rpcardio.com/jour/article/view/694
id doaj-2bc9a1d3fe8e4af1bb5f13ce8347dc73
record_format Article
spelling doaj-2bc9a1d3fe8e4af1bb5f13ce8347dc732021-09-03T13:15:18ZengStolichnaya Izdatelskaya KompaniyaRacionalʹnaâ Farmakoterapiâ v Kardiologii1819-64462225-36532016-01-0154859210.20996/1819-6446-2009-5-4-85-92693TO THE 110-TH ANNIVERSARY OF RENIN FINDING. FIGHT OF TITANS: ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND SARTANSL. N. Malay0A. N. Miroshnichenko1B. V. Sharykin2V. V. Konurovsky3Hospital of Federal Security Service of Russia in Khabarovsk TerritoryHospital of Federal Security Service of Russia in Khabarovsk TerritoryHospital of Federal Security Service of Russia in Khabarovsk TerritoryHospital of Federal Security Service of Russia in Khabarovsk TerritoryAngiotensin converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARB) slow down progression of cardiovascular diseases and reduce risk of mortality and life threatening complications. What it is better to prescribe for patient in a concrete clinical case – ACE inhibitors or ARB? Authors compare these drug classes (mechanism of action, indications, evidense base of clinical trails, treatment costs and safety). The place of ACE inhibitors and ARB in modern therapy of cardiovascular diseases is defined. Results of the recent trails (ONTARGET, TRANCEND, PRoFESS, I-PRESERVE) are discussed.https://www.rpcardio.com/jour/article/view/694angiotensin converting enzyme inhibitorsangiotensin ii receptor blockerscardiovascular diseases
collection DOAJ
language English
format Article
sources DOAJ
author L. N. Malay
A. N. Miroshnichenko
B. V. Sharykin
V. V. Konurovsky
spellingShingle L. N. Malay
A. N. Miroshnichenko
B. V. Sharykin
V. V. Konurovsky
TO THE 110-TH ANNIVERSARY OF RENIN FINDING. FIGHT OF TITANS: ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND SARTANS
Racionalʹnaâ Farmakoterapiâ v Kardiologii
angiotensin converting enzyme inhibitors
angiotensin ii receptor blockers
cardiovascular diseases
author_facet L. N. Malay
A. N. Miroshnichenko
B. V. Sharykin
V. V. Konurovsky
author_sort L. N. Malay
title TO THE 110-TH ANNIVERSARY OF RENIN FINDING. FIGHT OF TITANS: ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND SARTANS
title_short TO THE 110-TH ANNIVERSARY OF RENIN FINDING. FIGHT OF TITANS: ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND SARTANS
title_full TO THE 110-TH ANNIVERSARY OF RENIN FINDING. FIGHT OF TITANS: ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND SARTANS
title_fullStr TO THE 110-TH ANNIVERSARY OF RENIN FINDING. FIGHT OF TITANS: ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND SARTANS
title_full_unstemmed TO THE 110-TH ANNIVERSARY OF RENIN FINDING. FIGHT OF TITANS: ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND SARTANS
title_sort to the 110-th anniversary of renin finding. fight of titans: angiotensin converting enzyme inhibitors and sartans
publisher Stolichnaya Izdatelskaya Kompaniya
series Racionalʹnaâ Farmakoterapiâ v Kardiologii
issn 1819-6446
2225-3653
publishDate 2016-01-01
description Angiotensin converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARB) slow down progression of cardiovascular diseases and reduce risk of mortality and life threatening complications. What it is better to prescribe for patient in a concrete clinical case – ACE inhibitors or ARB? Authors compare these drug classes (mechanism of action, indications, evidense base of clinical trails, treatment costs and safety). The place of ACE inhibitors and ARB in modern therapy of cardiovascular diseases is defined. Results of the recent trails (ONTARGET, TRANCEND, PRoFESS, I-PRESERVE) are discussed.
topic angiotensin converting enzyme inhibitors
angiotensin ii receptor blockers
cardiovascular diseases
url https://www.rpcardio.com/jour/article/view/694
work_keys_str_mv AT lnmalay tothe110thanniversaryofreninfindingfightoftitansangiotensinconvertingenzymeinhibitorsandsartans
AT anmiroshnichenko tothe110thanniversaryofreninfindingfightoftitansangiotensinconvertingenzymeinhibitorsandsartans
AT bvsharykin tothe110thanniversaryofreninfindingfightoftitansangiotensinconvertingenzymeinhibitorsandsartans
AT vvkonurovsky tothe110thanniversaryofreninfindingfightoftitansangiotensinconvertingenzymeinhibitorsandsartans
_version_ 1717816884622000128

Similar Items